Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,245,670
+$107,957 QoQ
Shares Held
14,486
-0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#812
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $68,623,451 across 12 Drug Manufacturers - General names. AMGN ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437 | $18,515,602 | |
| 2 | JNJ |
Johnson & Johnson
|
69,174 | $17,568,120 | |
| 3 | ABBV |
AbbVie Inc.
|
43,329 | $10,903,309 | |
| 4 | MRK |
Merck & Co., Inc.
|
61,354 | $7,883,989 | |
| 5 | AMGN |
Amgen Inc
This page
|
14,486 | $5,245,670 | |
| 6 | PFE |
Pfizer Inc
|
154,501 | $3,720,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,027 | $1,787,775 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,109 | $1,277,171 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,245,670 | 14,486 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,137,713 | 14,602 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,980,348 | 15,216 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,856,827 | 13,667 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,188,578 | 11,420 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,646,069 | 11,703 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,082,849 | 11,828 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,218,695 | 13,093 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,865,006 | 12,370 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,231,012 | 11,364 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $3,014,705 | 10,467 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,693,243 | 10,021 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,961,324 | 8,834 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,043,512 | 8,453 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,257,653 | 8,596 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $2,024,092 | 8,980 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,242,982 | 9,219 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,778,102 | 7,353 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,896,947 | 8,432 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,552,982 | 7,303 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,811,062 | 7,430 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,916,085 | 7,701 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $764,943 | 3,327 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $660,053 | 2,597 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $671,021 | 2,845 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $464,048 | 2,289 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||